Guideline on the pharmaceutical quality of inhalation and nasal products

We have adopted this International Scientific Guideline – EMEA/CHMP/QWP/49313/2005 Corr

Overseas effective date: 1 October 2006

Categories: Quality | Specific types of products

TGA Annotations: Nil

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency - external site for further information.

Topics

Help us improve this page